ULVR · story · 4 November – 5 November
Unilever · 18 headlines from 16 outlets, from 4 November 2026 to 5 November 2026.
Numerous outlets cover Unilever's €35m spend on its research hubs in India, together with a bio-futures partnership.
The story's tone is the average of its headlines' own scores. Each score rates how good or bad the news was for the company, from −10 (clearly bad) to +10 (clearly good). 0 is neutral, and anything beyond ±6 is strong and rare. It rates the coverage, not the share price.
Average tone of each outlet's headlines in this story, −10 to +10. Impact = headlines × strength of tone.
WWD is the largest at 5.8, ahead of Personal Care Insights (5.8). Urban Acres is the smallest at 5.0.
Source: MarketFrame news analysis
| outlet | Average tone |
|---|---|
| TradingView | 5.4 |
| Urban Acres | 5.0 |
| WWD | 5.8 |
| Personal Care Insights | 5.8 |
| The New Indian Express | 5.8 |
| The Hindu | 5.8 |
| Storyboard18 | 5.8 |
| BW Businessworld | 5.8 |
| The Economic Times | 5.8 |
| Business Standard | 5.7 |
| Outlet | Headlines | Average tone |
|---|---|---|
| TradingView | 2 | +5.4 |
| Urban Acres | 2 | +5.0 |
| WWD | 1 | +5.8 |
| Personal Care Insights | 1 | +5.8 |
| The New Indian Express | 1 | +5.8 |
| The Hindu | 1 | +5.8 |
| Storyboard18 | 1 | +5.8 |
| BW Businessworld | 1 | +5.8 |
| The Economic Times | 1 | +5.8 |
| Business Standard | 1 | +5.7 |
| Outlet | Headlines | Average tone |
|---|---|---|
| The Financial Express | 1 | +5.7 |
| NDTV Profit | 1 | +5.5 |
| Equitypandit | 1 | +5.5 |
| Hindustan Unilever Limited | 1 | +5.5 |
| Livemint | 1 | +5.0 |
| Unilever Global | 1 | +5.0 |
One or two headlines is not a lean: read these as how this story was told, not as a verdict on the outlet.
| Tone | What the article reported, and why it scored that way |
|---|---|
| +5.8 | Commits funds to Indian research centres for future products. |
| +5.8 | Indian hubs to become AI-driven innovation base. |
| +5.8 | Funding for Indian research hubs with AI focus. |
| +5.8 | Heavy backing for AI and bio-science research in India. |
| +5.8 | Research and bio-futures spending in India. |
| +5.8 | AI and bioscience research funding in India. |
| +5.8 | Research expansion plus bio-futures push in India. |
| +5.8 | Expansion funding for two Indian research hubs. |
| Tone | What the article reported, and why it scored that way |
|---|---|
| +5.7 | Indian research hub investment and bio-futures partnership. |
| +5.7 | Research centre funding and bio-futures partnership. |
| +5.5 | Investment in Indian research capability. |
| +5.5 | Funding announced for Indian research hubs. |
| +5.5 | Company statement on strengthening Indian research capability. |
| +5.0 | Mumbai research site to become innovation centre. |
| +5.0 | Research hub investment in two Indian cities. |
| +5.0 | Indian research hubs being enlarged. |
| +5.0 | CEO sees India as a major growth engine. |
| Tone | What the article reported, and why it scored that way |
|---|---|
| +5.0 | Investment expands research and innovation capacity in India. |
A short, free morning email on how the news treated Unilever: the tone, the stories behind it, and when coverage starts to turn. Launching soon; one click to unsubscribe.